Skip to content

NeuroDerm eyes possible sale

June 15, 2017

NeuroDerm (NASDAQ: NDRM) is weighing a sale of the company, according to Bloomberg which cited people familiar with the matter.

The company is working with an unnamed financial adviser on the possible sale.

The company has attracted interest from other big drug makers with a presence in the central nervous system business, the report added.

Valuation is said to be the biggest hurdle to a possible deal and talks may not lead to a deal.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: